Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
Astec LifeSciences IPO is a book build issue of ₹61.50 crores. The issue is entirely a fresh issue of 0.75 crore shares of ₹61.50 crore.
Astec LifeSciences IPO bidding started from Oct 29, 2009 and ended on Nov 4, 2009. The shares got listed on BSE, NSE on Nov 25, 2009.
Astec LifeSciences IPO price band is set at ₹82.00 per share . The lot size for an application is 75. The minimum amount of investment required by an retail is ₹5,775 (75 shares). The lot size investment for sNII is 33 lots (2,475 shares), amounting to ₹2,02,950, and for bNII, it is 163 lots (12,225 shares), amounting to ₹10,02,450.
The issue includes a reservation of up to 1,00,000 shares for employees offered at a discount of ₹0.00 to the issue price.
Almondz Global Securities Ltd. is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue.
Refer to Astec LifeSciences IPO RHP for detailed Information.
| IPO Date | October 29, 2009 to November 4, 2009 |
| Listing Date | November 25, 2009 |
| Face Value | ₹10 per share |
| Issue Price Band | ₹77 to ₹82 per share |
| Issue Price Final | ₹82 per share |
| Lot Size | 75 Shares |
| Sale Type | Fresh Capital |
| Total Issue Size | 75,00,150 shares (aggregating up to ₹61.50 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 94,28,980 shares |
| Share Holding Post Issue | 1,69,28,980 shares |
Astec IPO offers total 75,00,000 shares. Out of which 37,00,000 (49.33%) allocated to QIB, 11,10,000 (14.80%) allocated to NII, 25,90,000 (34.53%) allocated to RII.
| Investor Category | Shares Offered | Maximum Allottees |
|---|---|---|
| QIB Shares Offered | 37,00,000 (49.33%) | NA |
| NII (HNI) Shares Offered | 11,10,000 (14.80%) | NA |
| Retail Shares Offered | 25,90,000 (34.53%) | 34,533 |
| Employee Shares Offered | 1,00,000 (1.33%) | NA |
| Total Shares Offered | 75,00,000 (100.00%) |
| Application Category | Maximum Bidding Limits | Bidding at Cut-off Price Allowed |
|---|---|---|
| Only RII | Up to Rs 2 Lakhs | Yes |
| Only sNII | Rs 2 Lakhs to Rs 10 Lakhs | No |
| Only bNII | Rs 10 Lakhs to NII Reservation Portion | No |
| Only employee | Yes | |
| Employee + RII/NII |
|
Yes for Employee and RII/NII |
Astec LifeSciences IPO opens on October 29, 2009, and closes on November 4, 2009.
| IPO Open Date | Thu, Oct 29, 2009 |
| IPO Close Date | Wed, Nov 4, 2009 |
| Tentative Listing Date | Wed, Nov 25, 2009 |
| Cut-off time for UPI mandate confirmation | 5 PM on Wed, Nov 4, 2009 |
Investors can bid for a minimum of 75 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 75 | ₹6,150 |
| Retail (Max) | 32 | 2,400 | ₹1,96,800 |
| S-HNI (Min) | 33 | 2,475 | ₹2,02,950 |
| S-HNI (Max) | 162 | 12,150 | ₹9,96,300 |
| B-HNI (Min) | 163 | 12,225 | ₹10,02,450 |
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue
Incorporated in 1994, Astec LifeSciences Limited is engaged in business of Agrochemicals and Pharmaceuticals. Company is primarily involved in the production of active ingredients and intermediates for agrochemicals and pharmaceutical segment. Hexaconazole, Tebuconazole, Metalaxyl and Propiconazole are some of their key products in agrochemical segment which are generally used in crop protection and Dicap is one of the key Pharmaceutical intermediate which is used in manufacture of antifungal agents.
Astec has multipurpose production facilities at 2 locations.
1. Dombivli - 1 plant (50km from Mumbai)
2. Mahad - 2 plants ( 180 kms from Mumbai)
Astec started it's first manufacturing unit in August 1994 in Dombivli, Maharashtra having an installed capacity of 120 MT for the manufacture of Dicap. In the year of 2002, Astec entered into an agreement with Behram Chemicals Private Limited for using and operating their manufacturing facilities located at Mahad Industrial Area, Maharashtra. During 2003-04 company expanded the total installed capacity of their units (Dombivli and Mahad) from 250 MT to 500 MT.
Astec has been granted ISO 9001:2000 Certificate of Assessment by International Standards Certification Pvt limited, Australia for “Design, Development, Manufacture and Supply of Organic Chemical and Intermediates for Pharmaceutical and Agrochemical Industry”.
| KPI | Values |
|---|---|
| RoNW | 35.15% |
The Company Astec IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:
| S.No. | Objects of the Issue | Expected Amount (in Millions) |
|---|---|---|
| 1 | Expansion of our existing manufacturing facilities at Mahad, Maharashtra | 325.62 |
| 2 | Expansion of our existing Research and Development facility at Dombivli, Maharashtra | 25.55 |
| 3 | Contingencies @ 2.5% of the above expansion project | 8.78 |
| 4 | Meeting Product Registration expenses | 37.55 |
| 5 | Meeting long-term working capital requirements | 110.00 |
| 6 | General Corporate Purposes | 70.51 |
| 7 | Issue Expenses | 67.00 |
CARE has assigned an IPO Grade 2 to Astec LifeSciences Limited IPO. This means as per CARE, company has below average fundamentals. CARE assigns IPO gradings on a scale of 5 to 1, with Grade 5 indicating strong fundamentals and Grade 1 indicating poor fundamentals. Link to download CARE rating document.
| Listing Date | November 25, 2009 |
| BSE Script Code | 533138 |
| NSE Symbol | ASTEC |
| ISIN | INE563J01010 |
| Final Issue Price | ₹82 per share |
| BSE Listing Group | B |
Astec LifeSciences Ltd.
5-5A, 4th floor,
Kamanwala Chambers, Sir P. M. Road,
Fort, Mumbai - 400001
Fort, Maharashtra
Phone: +91-22-2261 8212-13
Email: ipo@astecls.com
Website: http://www.astecls.com
Bigshare Services Pvt.Ltd.
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html
Astec LifeSciences IPO is a main-board IPO of 75,00,150 equity shares of the face value of ₹10 aggregating up to ₹61.50 Crores. The issue is priced at ₹82 per share. The minimum order quantity is 75.
The IPO opens on October 29, 2009, and closes on November 4, 2009.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Astec LifeSciences IPO using UPI as a payment gateway. Zerodha customers can apply in Astec LifeSciences IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Astec LifeSciences IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Astec LifeSciences IPO opens on October 29, 2009 and closes on November 4, 2009.
Astec LifeSciences IPO lot size is 75, and the minimum amount required for application is ₹6,150.
You can apply in Astec LifeSciences IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Astec LifeSciences IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Astec LifeSciences IPO allotment status.
The Astec LifeSciences IPO listing date is on Wednesday, November 25, 2009.
Useful Articles
RHP